Key Figures
| Multi-year comparison MedCap group | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017* | 2016/2017 | 2015/2016 | 2014/2015 |
| Net Sales, MSEK | 1 587.4 | 1 111.3 | 916.3 | 817.4 | 757.1 | 709.0 | 411.2 | 851.7 | 816.9 | 852.8 |
| EBITDA, MSEK | 347.0 | 258.7 | 202.5 | 157.2 | 140.0 | 77.6 | 41.5 | 30.3 | 55.3 | 31.0 |
| Equity/assets ratio | 62% | 60% | 60% | 55% | 39% | 41% | 44% | 48% | 48% | 49% |
| Equity/share (SEK) | 68.8 | 57.8 | 47.0 | 40.3 | 24.2 | 20.2 | 19.8 | 21.0 | 21.0 | 19.9 |
| Market price/share (SEK) | 337.5 | 216.5 | 178.0 | 230.0 | 139.0 | 79.4 | 45.0 | 30.5 | 30.5 | 27.6 |
| *) 8 months (1 May - 31 August | ||||||||||
Become a part of MedCap
Here you will find more information about our investment strategy and about MedCap as owner.